Showing results (21-30 of 72) with videos related to

Sort By:
Pageof 8
The Pharmacogenomics Journal|December 10, 2009
Alternative-splicing forms of the major phase II conjugating UGT1A gene negatively regulate glucuronidation in human carcinoma cell linesJ Bellemare, M Rouleau, M Harvey, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|January 1, 1989
Frequency of alpha-fetoprotein production by Sertoli-Leydig cell tumors of the ovary: an immunohistochemical study of eight casesS Gagnon, B Têtu, E G Silva, et al.
The American Journal of Pathology|February 1, 1997
Immunohistochemical study suggesting a complementary role of kallikreins hK2 and hK3 (prostate-specific antigen) in the functional analysis of human prostate tumorsR R Tremblay, D Deperthes, B Têtu, et al.
Human Pathology|September 1, 1996
Prognostic significance of nuclear DNA content and S-phase fraction by flow cytometry in primary papillary superficial bladder cancerB Têtu, P Allard, Y Fradet, et al.
Cancer|July 15, 1986
Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). II. An immunohistochemical and electron microscopic studyB Têtu, N G Ordóñez, A G Ayala, et al.
Cancer|July 15, 1986
Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). I. A clinicopathologic study of 26 casesS Johnson, B Têtu, A G Ayala, et al.
The Prostate|January 1, 1989
Synthesis of alpha 1-acid glycoprotein by the human prostateJ Y Dubé, G Paradis, B Têtu, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|January 1, 1996
Markers of chemoresistance in ovarian carcinomas: an immunohistochemical study of 86 casesI Germain, B Têtu, J Brisson, et al.
Gynecologic Oncology|January 22, 2005
Lymph node metastases in low-grade endometrial stromal sarcomaJ Riopel, M Plante, M-C Renaud, et al.
Breast Cancer Research and Treatment|August 1, 1997
mdr1 mRNA expression by RT-PCR in patients with primary breast cancer submitted to neoadjuvant therapyC S Wang, H LaRue, A Fortin, et al.
Pageof 8